$OXBT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in TENAX THERAPEUTICS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in TENAX THERAPEUTICS, INC.. Get notifications about new insider transactions in TENAX THERAPEUTICS, INC. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 27 2021 | OXBT | TENAX THERAPEUTICS ... | Rich Stuart | Chief Medical Offic ... | Option Exercise | A | 1.78 | 250,000 | 445,000 | 250,000 | |
Jan 27 2021 | OXBT | TENAX THERAPEUTICS ... | Rich Stuart | Chief Medical Offic ... | Grant | A | 0.00 | 3,581 | 0 | 3,581 | 0 to 3.6 K |
Jan 27 2021 | OXBT | TENAX THERAPEUTICS ... | Rich Stuart | Chief Medical Offic ... | Grant | A | 0.00 | 662,517 | 0 | 662,517 | 0 to 662.5 K |
Jan 12 2021 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | CFO | Option Exercise | A | 1.85 | 70,000 | 129,500 | 70,000 | |
Jan 12 2021 | OXBT | TENAX THERAPEUTICS ... | DiTonno Anthony A | CEO | Option Exercise | A | 1.85 | 90,000 | 166,500 | 90,000 | |
Sep 09 2020 | OXBT | TENAX THERAPEUTICS ... | ARMISTICE CAPITAL, LLC | Director | Buy | P | 1.46 | 8,543 | 12,473 | 2,019,995 | 2 M to 2 M (+0.42 %) |
Sep 09 2020 | OXBT | TENAX THERAPEUTICS ... | ARMISTICE CAPITAL, LLC | Director | Buy | P | 1.41 | 23,457 | 33,074 | 2,011,452 | 2 M to 2 M (+1.18 %) |
Sep 03 2020 | OXBT | TENAX THERAPEUTICS ... | ARMISTICE CAPITAL, LLC | Director | Buy | P | 1.39 | 36,000 | 50,040 | 1,987,995 | 2 M to 2 M (+1.84 %) |
Sep 03 2020 | OXBT | TENAX THERAPEUTICS ... | ARMISTICE CAPITAL, LLC | Director | Buy | P | 1.47 | 20,000 | 29,400 | 1,951,995 | 1.9 M to 2 M (+1.04 %) |
Sep 03 2020 | OXBT | TENAX THERAPEUTICS ... | ARMISTICE CAPITAL, LLC | Director | Buy | P | 1.46 | 30,000 | 43,800 | 1,931,995 | 1.9 M to 1.9 M (+1.58 %) |
Aug 31 2020 | OXBT | TENAX THERAPEUTICS ... | ARMISTICE CAPITAL, LLC | Director | Buy | P | 1.45 | 20,000 | 29,000 | 1,901,995 | 1.9 M to 1.9 M (+1.06 %) |
Aug 31 2020 | OXBT | TENAX THERAPEUTICS ... | ARMISTICE CAPITAL, LLC | Director | Buy | P | 1.50 | 12,000 | 18,000 | 1,881,995 | 1.9 M to 1.9 M (+0.64 %) |
Aug 31 2020 | OXBT | TENAX THERAPEUTICS ... | ARMISTICE CAPITAL, LLC | Director | Buy | P | 1.45 | 20,000 | 29,000 | 1,901,995 | 1.9 M to 1.9 M (+1.06 %) |
Aug 31 2020 | OXBT | TENAX THERAPEUTICS ... | ARMISTICE CAPITAL, LLC | Director | Buy | P | 1.50 | 12,000 | 18,000 | 1,881,995 | 1.9 M to 1.9 M (+0.64 %) |
Aug 26 2020 | OXBT | TENAX THERAPEUTICS ... | ARMISTICE CAPITAL, LLC | 10% Owner | Buy | P | 1.50 | 12,000 | 18,000 | 1,869,995 | 1.9 M to 1.9 M (+0.65 %) |
Aug 26 2020 | OXBT | TENAX THERAPEUTICS ... | ARMISTICE CAPITAL, LLC | 10% Owner | Buy | P | 1.53 | 17,211 | 26,333 | 1,857,995 | 1.8 M to 1.9 M (+0.93 %) |
Aug 26 2020 | OXBT | TENAX THERAPEUTICS ... | ARMISTICE CAPITAL, LLC | 10% Owner | Buy | P | 1.47 | 5,692 | 8,367 | 1,840,784 | 1.8 M to 1.8 M (+0.31 %) |
Aug 21 2020 | OXBT | TENAX THERAPEUTICS ... | ARMISTICE CAPITAL, LLC | Director | Buy | P | 1.44 | 116,242 | 167,388 | 1,835,092 | 1.7 M to 1.8 M (+6.76 %) |
Aug 21 2020 | OXBT | TENAX THERAPEUTICS ... | ARMISTICE CAPITAL, LLC | Director | Buy | P | 1.53 | 124,472 | 190,442 | 1,718,850 | 1.6 M to 1.7 M (+7.81 %) |
Aug 21 2020 | OXBT | TENAX THERAPEUTICS ... | ARMISTICE CAPITAL, LLC | Director | Buy | P | 1.45 | 70,767 | 102,612 | 1,594,378 | 1.5 M to 1.6 M (+4.64 %) |
Jun 15 2020 | OXBT | TENAX THERAPEUTICS ... | RALLIS CHRIS A | Option Exercise | A | 1.72 | 500 | 860 | 500 | ||
Jun 15 2020 | OXBT | TENAX THERAPEUTICS ... | RALLIS CHRIS A | Option Exercise | A | 0.66 | 500 | 330 | 500 | ||
May 19 2020 | OXBT | TENAX THERAPEUTICS ... | BLANCK RONALD R | Buy | P | 0.95 | 5,000 | 4,774 | 6,062 | 1.1 K to 6.1 K (+470.81 %) | |
May 15 2020 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | CFO | Option Exercise | A | 1.18 | 75,000 | 88,500 | 75,000 | |
May 15 2020 | OXBT | TENAX THERAPEUTICS ... | PROEHL GERALD T | Option Exercise | A | 0.66 | 500 | 330 | 500 | ||
May 15 2020 | OXBT | TENAX THERAPEUTICS ... | Mitchum James P. | Option Exercise | A | 0.66 | 500 | 330 | 500 | ||
May 15 2020 | OXBT | TENAX THERAPEUTICS ... | BLANCK RONALD R | Option Exercise | A | 0.66 | 500 | 330 | 500 | ||
May 15 2020 | OXBT | TENAX THERAPEUTICS ... | DiTonno Anthony A | CEO | Option Exercise | A | 1.18 | 75,000 | 88,500 | 75,000 | |
Apr 22 2019 | OXBT | TENAX THERAPEUTICS ... | DiTonno Anthony A | CEO | Option Exercise | A | 6.10 | 50,000 | 305,000 | 50,000 | |
Apr 18 2019 | OXBT | TENAX THERAPEUTICS ... | Mitchum James P. | Option Exercise | A | 6.23 | 500 | 3,115 | 500 | ||
Apr 18 2019 | OXBT | TENAX THERAPEUTICS ... | DiTonno Anthony A | Option Exercise | A | 6.23 | 500 | 3,115 | 500 | ||
Apr 18 2019 | OXBT | TENAX THERAPEUTICS ... | BLANCK RONALD R | Option Exercise | A | 6.23 | 500 | 3,115 | 500 | ||
Apr 18 2019 | OXBT | TENAX THERAPEUTICS ... | PROEHL GERALD T | Option Exercise | A | 6.23 | 500 | 3,115 | 500 | ||
Aug 07 2018 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | CFO | Buy | D | 6.25 | 5,720 | 35,750 | 34,680 | 29 K to 34.7 K (+19.75 %) |
Apr 05 2018 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | CFO | Buy | D | 5.42 | 6,425 | 34,824 | 12,310 | 5.9 K to 12.3 K (+109.18 %) |
Jan 02 2018 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | CFO | Buy | D | 0.43 | 98 | 42 | 68,264 | 68.2 K to 68.3 K (+0.14 %) |
Dec 20 2017 | OXBT | TENAX THERAPEUTICS ... | BLANCK RONALD R | Buy | P | 0.45 | 6,475 | 2,881 | 20,099 | 13.6 K to 20.1 K (+47.53 %) | |
Dec 20 2017 | OXBT | TENAX THERAPEUTICS ... | BLANCK RONALD R | Buy | P | 0.46 | 6,475 | 3,006 | 13,624 | 7.1 K to 13.6 K (+90.57 %) | |
Nov 20 2017 | OXBT | TENAX THERAPEUTICS ... | BLANCK RONALD R | Sell | S | 0.39 | 12,950 | 5,051 | 7,149 | 20.1 K to 7.1 K (-64.43 %) | |
Jul 31 2017 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | CFO | Buy | D | 0.65 | 54 | 35 | 68,146 | 68.1 K to 68.1 K (+0.08 %) |
Apr 18 2017 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | CFO | Buy | D | 0.54 | 56 | 30 | 68,200 | 68.1 K to 68.2 K (+0.08 %) |
Apr 05 2017 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | Interim CEO, Presid ... | Option Exercise | A | 0.53 | 200,000 | 106,000 | 200,000 | |
Mar 20 2017 | OXBT | TENAX THERAPEUTICS ... | Kelley John P | Chief Executive Off ... | Payment of Exercise | F | 0.68 | 96,999 | 65,959 | 1,282,932 | 1.4 M to 1.3 M (-7.03 %) |
Mar 20 2017 | OXBT | TENAX THERAPEUTICS ... | Kelley John P | Chief Executive Off ... | Grant | A | 0.00 | 213,420 | 0 | 1,379,931 | 1.2 M to 1.4 M (+18.30 %) |
Dec 20 2016 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | Chief Financial Off ... | Option Exercise | A | 2.07 | 150,000 | 310,500 | 150,000 | |
Dec 20 2016 | OXBT | TENAX THERAPEUTICS ... | Kelley John P | Chief Executive Off ... | Option Exercise | A | 2.07 | 120,000 | 248,400 | 120,000 | |
Dec 20 2016 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | CFO | Buy | D | 2.07 | 49 | 101 | 68,256 | 68.2 K to 68.3 K (+0.07 %) |
Nov 29 2016 | OXBT | TENAX THERAPEUTICS ... | PROEHL GERALD T | Director | Buy | P | 1.76 | 14,449 | 25,430 | 29,882 | 15.4 K to 29.9 K (+93.62 %) |
Nov 29 2016 | OXBT | TENAX THERAPEUTICS ... | PROEHL GERALD T | Director | Buy | P | 1.59 | 15,433 | 24,538 | 15,433 | 0 to 15.4 K |
Nov 22 2016 | OXBT | TENAX THERAPEUTICS ... | Mitchum James P. | Director | Buy | D | 1.51 | 7,000 | 10,570 | 26,000 | 19 K to 26 K (+36.84 %) |
Oct 20 2016 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | CFO | Sell | D | 2.32 | 49 | 114 | 68,305 | 68.4 K to 68.3 K (-0.07 %) |
Oct 20 2016 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | CFO | Sell | D | 2.72 | 55 | 150 | 68,354 | 68.4 K to 68.4 K (-0.08 %) |
Oct 20 2016 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | CFO | Grant | A | 2.72 | 430 | 1,170 | 68,409 | 68 K to 68.4 K (+0.63 %) |
Aug 22 2016 | OXBT | TENAX THERAPEUTICS ... | RALLIS CHRIS A | Director | Buy | D | 2.50 | 10,000 | 25,000 | 14,490 | 4.5 K to 14.5 K (+222.72 %) |
May 27 2016 | OXBT | TENAX THERAPEUTICS ... | BLANCK RONALD R | Director | Buy | D | 2.62 | 3,500 | 9,170 | 20,099 | 16.6 K to 20.1 K (+21.09 %) |
Apr 06 2016 | OXBT | TENAX THERAPEUTICS ... | BLANCK RONALD R | Director | Buy | D | 2.69 | 1,800 | 4,842 | 16,599 | 14.8 K to 16.6 K (+12.16 %) |
Apr 04 2016 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | CFO | Buy | D | 2.65 | 56 | 148 | 67,979 | 67.9 K to 68 K (+0.08 %) |
Feb 19 2016 | OXBT | TENAX THERAPEUTICS ... | Mitchum James P. | Director | Buy | P | 2.65 | 13,900 | 36,835 | 19,000 | 5.1 K to 19 K (+272.55 %) |
Feb 19 2016 | OXBT | TENAX THERAPEUTICS ... | Mitchum James P. | Director | Buy | P | 2.68 | 5,100 | 13,668 | 5,100 | 0 to 5.1 K |
Nov 19 2015 | OXBT | TENAX THERAPEUTICS ... | BLANCK RONALD R | Director | Buy | P | 3.20 | 1,900 | 6,080 | 14,799 | 12.9 K to 14.8 K (+14.73 %) |
Nov 09 2015 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | CFO | Buy | D | 3.19 | 49 | 156 | 68,035 | 68 K to 68 K (+0.07 %) |
Aug 18 2015 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | CFO | Buy | D | 3.68 | 49 | 180 | 68,084 | 68 K to 68.1 K (+0.07 %) |
Jun 26 2015 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | CFO | Buy | D | 3.42 | 430 | 1,471 | 68,133 | 67.7 K to 68.1 K (+0.64 %) |
May 15 2015 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | CFO | Buy | D | 3.44 | 55 | 189 | 67,703 | 67.6 K to 67.7 K (+0.08 %) |
Feb 18 2015 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | CFO | Buy | D | 3.28 | 56 | 184 | 67,758 | 67.7 K to 67.8 K (+0.08 %) |
Jan 20 2015 | OXBT | TENAX THERAPEUTICS ... | BLANCK RONALD R | Director | Buy | P | 3.49 | 2,000 | 6,980 | 10,199 | 8.2 K to 10.2 K (+24.39 %) |
Dec 02 2014 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | CFO | Buy | D | 3.94 | 49 | 193 | 67,814 | 67.8 K to 67.8 K (+0.07 %) |
Aug 06 2014 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | CFO | Buy | D | 3.91 | 50 | 196 | 67,863 | 67.8 K to 67.9 K (+0.07 %) |
Aug 04 2014 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | Chief Finanacial Of ... | Grant | A | 4.98 | 430 | 2,141 | 67,913 | 67.5 K to 67.9 K (+0.64 %) |
Jul 15 2014 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | Chief Financial Off ... | Buy | D | 4.67 | 14,761 | 68,934 | 67,483 | 52.7 K to 67.5 K (+28.00 %) |
Apr 16 2014 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | Chief Financial Off ... | Buy | D | 5.55 | 15 | 83 | 82,244 | 82.2 K to 82.2 K (+0.02 %) |
Mar 17 2014 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | President and CFO | Buy | D | 6.47 | 16 | 104 | 82,259 | 82.2 K to 82.3 K (+0.02 %) |
Mar 10 2014 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | Chief Financial Off ... | Grant | A | 7.00 | 32,143 | 225,001 | 82,335 | 50.2 K to 82.3 K (+64.04 %) |
Feb 19 2014 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | Chief Financial Off ... | Buy | D | 6.18 | 16 | 99 | 50,132 | 50.1 K to 50.1 K (+0.03 %) |
Jan 21 2014 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | Chief Financial Off ... | Buy | D | 4.50 | 16 | 72 | 50,148 | 50.1 K to 50.1 K (+0.03 %) |
Dec 18 2013 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | Chief Financial Off ... | Buy | D | 6.27 | 14 | 88 | 50,164 | 50.2 K to 50.2 K (+0.03 %) |
Nov 15 2013 | OXBT | TENAX THERAPEUTICS ... | Kelley John P | Chief Executive Off ... | Grant | A | 0.00 | 8,248 | 0 | 8,248 | 0 to 8.2 K |
Nov 15 2013 | OXBT | TENAX THERAPEUTICS ... | Kelley John P | Chief Executive Off ... | Grant | A | 0.00 | 341,711 | 0 | 341,711 | 0 to 341.7 K |
Nov 15 2013 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | Chief Financial Off ... | Buy | D | 3.04 | 14 | 43 | 50,178 | 50.2 K to 50.2 K (+0.03 %) |
Oct 09 2013 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | Chief Financial Off ... | Grant | A | 1.32 | 79,546 | 105,001 | 50,206 | -29,340 to 50.2 K (-271.12 %) |
Oct 16 2013 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | Chief Financial Off ... | Buy | D | 1.47 | 14 | 21 | 50,192 | 50.2 K to 50.2 K (+0.03 %) |
Sep 17 2013 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | Chief Financial Off ... | Buy | D | 1.32 | 14 | 18 | 1,621 | 1.6 K to 1.6 K (+0.87 %) |
Aug 23 2013 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | Chief Financial Off ... | Buy | D | 1.59 | 14 | 22 | 1,635 | 1.6 K to 1.6 K (+0.86 %) |
Jul 30 2013 | OXBT | TENAX THERAPEUTICS ... | RALLIS CHRIS A | Director | Option Exercise | P | 2.60 | 2,565 | 6,669 | 2,565 | |
Jul 30 2013 | OXBT | TENAX THERAPEUTICS ... | RALLIS CHRIS A | Director | Option Exercise | P | 1.95 | 5 | 10 | 5 | |
Jul 26 2013 | OXBT | TENAX THERAPEUTICS ... | BLANCK RONALD R | Director | Option Exercise | P | 2.60 | 5,129 | 13,335 | 5,129 | |
Jul 26 2013 | OXBT | TENAX THERAPEUTICS ... | BLANCK RONALD R | Director | Option Exercise | P | 1.95 | 10 | 20 | 10 | |
Jul 26 2013 | OXBT | TENAX THERAPEUTICS ... | DiTonno Anthony A | Director | Option Exercise | P | 2.60 | 2,565 | 6,669 | 2,565 | |
Jul 26 2013 | OXBT | TENAX THERAPEUTICS ... | DiTonno Anthony A | Director | Option Exercise | P | 1.95 | 5 | 10 | 5 | |
Jul 16 2013 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | Chief Financial Off ... | Buy | D | 2.96 | 14 | 41 | 1,649 | 1.6 K to 1.6 K (+0.86 %) |
Jul 01 2013 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | Chief Financial Off ... | Buy | D | 3.73 | 14 | 52 | 1,663 | 1.6 K to 1.7 K (+0.85 %) |
Jun 04 2013 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | Chief Financial Off ... | Buy | D | 0.25 | 279 | 70 | 33,534 | 33.3 K to 33.5 K (+0.84 %) |
Jun 04 2013 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | Chief Financial Off ... | Grant | A | 0.25 | 8,600 | 2,150 | 33,813 | 25.2 K to 33.8 K (+34.11 %) |
Apr 15 2013 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | Chief Financial Off ... | Buy | D | 0.25 | 322 | 81 | 25,213 | 24.9 K to 25.2 K (+1.29 %) |
Feb 19 2013 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | Chief Financial Off ... | Buy | D | 0.68 | 324 | 220 | 25,859 | 25.5 K to 25.9 K (+1.27 %) |
Mar 15 2013 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | Chief Financial Off ... | Buy | D | 0.28 | 324 | 91 | 25,535 | 25.2 K to 25.5 K (+1.29 %) |
Jan 17 2013 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | Chief Financial Off ... | Buy | D | 0.64 | 324 | 207 | 26,183 | 25.9 K to 26.2 K (+1.25 %) |
Dec 18 2012 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | Chief Financial Off ... | Buy | D | 0.69 | 279 | 193 | 26,507 | 26.2 K to 26.5 K (+1.06 %) |
Nov 19 2012 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | Chief Financial Off ... | Buy | D | 1.05 | 279 | 293 | 26,786 | 26.5 K to 26.8 K (+1.05 %) |
Oct 16 2012 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | Chief Financial Off ... | Buy | D | 0.60 | 279 | 167 | 27,065 | 26.8 K to 27.1 K (+1.04 %) |
Sep 17 2012 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | Chief Financial Off ... | Buy | D | 0.88 | 279 | 246 | 27,344 | 27.1 K to 27.3 K (+1.03 %) |
Sep 17 2012 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | Chief Financial Off ... | Grant | A | 1.84 | 14,938 | 27,486 | 27,623 | 12.7 K to 27.6 K (+117.76 %) |
Aug 15 2012 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | Chief Financial Off ... | Buy | D | 1.07 | 279 | 299 | 12,685 | 12.4 K to 12.7 K (+2.25 %) |
Jul 16 2012 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | Chief Financial Off ... | Buy | D | 1.57 | 279 | 438 | 12,964 | 12.7 K to 13 K (+2.20 %) |
Jul 16 2012 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | Chief Financial Off ... | Buy | D | 2.01 | 279 | 561 | 13,243 | 13 K to 13.2 K (+2.15 %) |
Jun 14 2012 | OXBT | TENAX THERAPEUTICS ... | Chatfield William A. | Director | Grant | A | 1.78 | 18,961 | 33,751 | 42,289 | 23.3 K to 42.3 K (+81.28 %) |
Jun 14 2012 | OXBT | TENAX THERAPEUTICS ... | Chatfield William A. | Director | Grant | A | 1.78 | 18,961 | 33,751 | 42,289 | 23.3 K to 42.3 K (+81.28 %) |
Jun 14 2012 | OXBT | TENAX THERAPEUTICS ... | DiTonno Anthony A | Director | Option Exercise | A | 1.78 | 25,391 | 45,196 | 35,200 | |
Jun 14 2012 | OXBT | TENAX THERAPEUTICS ... | RALLIS CHRIS A | Director | Grant | A | 1.78 | 18,680 | 33,250 | 25,773 | 7.1 K to 25.8 K (+263.36 %) |
Jun 14 2012 | OXBT | TENAX THERAPEUTICS ... | BLANCK RONALD R | Director | Grant | A | 1.78 | 18,961 | 33,751 | 43,479 | 24.5 K to 43.5 K (+77.34 %) |
May 15 2012 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | Chief Financial Off ... | Buy | D | 1.78 | 279 | 497 | 13,522 | 13.2 K to 13.5 K (+2.11 %) |
May 15 2012 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | Chief Financial Off ... | Grant | A | 1.78 | 8,600 | 15,308 | 13,801 | 5.2 K to 13.8 K (+165.35 %) |
Apr 17 2012 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | Chief Financial Off ... | Buy | D | 2.35 | 307 | 721 | 5,201 | 4.9 K to 5.2 K (+6.27 %) |
Mar 16 2012 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | Chief Financial Off ... | Buy | D | 2.69 | 309 | 831 | 5,508 | 5.2 K to 5.5 K (+5.94 %) |
Feb 15 2012 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | President and CFO | Buy | D | 2.00 | 309 | 618 | 5,817 | 5.5 K to 5.8 K (+5.61 %) |
Feb 06 2012 | OXBT | TENAX THERAPEUTICS ... | BLANCK RONALD R | Director | Grant | A | 2.11 | 9,538 | 20,125 | 17,028 | 7.5 K to 17 K (+127.34 %) |
Feb 06 2012 | OXBT | TENAX THERAPEUTICS ... | BLANCK RONALD R | Director | Grant | A | 2.52 | 7,490 | 18,875 | 7,490 | 0 to 7.5 K |
Jan 17 2012 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | Chief Financial Off ... | Buy | D | 1.43 | 309 | 442 | 6,126 | 5.8 K to 6.1 K (+5.31 %) |
Dec 20 2011 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | Chief Financial Off ... | Buy | D | 1.91 | 279 | 533 | 6,435 | 6.2 K to 6.4 K (+4.53 %) |
Nov 16 2011 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | Chief Financial Off ... | Buy | D | 2.11 | 279 | 589 | 6,714 | 6.4 K to 6.7 K (+4.34 %) |
Oct 19 2011 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | Chief Financial Off ... | Payment of Exercise | F | 2.09 | 279 | 583 | 6,993 | 7.3 K to 7 K (-3.84 %) |
Oct 19 2011 | OXBT | TENAX THERAPEUTICS ... | Klein Gerald L | Chief Medical Offic ... | Payment of Exercise | F | 2.09 | 243 | 508 | 13,542 | 13.8 K to 13.5 K (-1.76 %) |
Sep 16 2011 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | Chief Financial Off ... | Payment of Exercise | F | 2.28 | 279 | 636 | 7,272 | 7.6 K to 7.3 K (-3.69 %) |
Aug 10 2011 | OXBT | TENAX THERAPEUTICS ... | Klein Gerald L | Chief Medical Offic ... | Payment of Exercise | F | 2.47 | 243 | 600 | 14,028 | 14.3 K to 14 K (-1.70 %) |
Sep 16 2011 | OXBT | TENAX THERAPEUTICS ... | Klein Gerald L | Chief Medical Offic ... | Payment of Exercise | F | 2.28 | 243 | 554 | 13,785 | 14 K to 13.8 K (-1.73 %) |
Aug 10 2011 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | Chief Financial Off ... | Payment of Exercise | F | 2.47 | 279 | 689 | 7,551 | 7.8 K to 7.6 K (-3.56 %) |
Aug 10 2011 | OXBT | TENAX THERAPEUTICS ... | Stern Christian J | Chief Executive Off ... | Payment of Exercise | F | 2.47 | 643 | 1,588 | 147,607 | 148.3 K to 147.6 K (-0.43 %) |
Aug 08 2011 | OXBT | TENAX THERAPEUTICS ... | Stern Christian J | Chief Executive Off ... | Payment of Exercise | F | 2.99 | 4,470 | 13,365 | 148,250 | 152.7 K to 148.3 K (-2.93 %) |
Aug 08 2011 | OXBT | TENAX THERAPEUTICS ... | Stern Christian J | Chief Executive Off ... | Payment of Exercise | F | 1.98 | 643 | 1,273 | 152,720 | 153.4 K to 152.7 K (-0.42 %) |
Aug 08 2011 | OXBT | TENAX THERAPEUTICS ... | Stern Christian J | Chief Executive Off ... | Payment of Exercise | F | 1.77 | 643 | 1,138 | 153,363 | 154 K to 153.4 K (-0.42 %) |
Aug 08 2011 | OXBT | TENAX THERAPEUTICS ... | Klein Gerald L | Chief Medical Offic ... | Payment of Exercise | F | 2.99 | 243 | 727 | 14,271 | 14.5 K to 14.3 K (-1.67 %) |
Aug 08 2011 | OXBT | TENAX THERAPEUTICS ... | Klein Gerald L | Chief Medical Offic ... | Payment of Exercise | F | 1.98 | 243 | 481 | 14,514 | 14.8 K to 14.5 K (-1.65 %) |
Aug 08 2011 | OXBT | TENAX THERAPEUTICS ... | Klein Gerald L | Chief Medical Offic ... | Payment of Exercise | F | 1.98 | 243 | 481 | 14,757 | 15 K to 14.8 K (-1.62 %) |
Aug 08 2011 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | Chief Financial Off ... | Payment of Exercise | F | 2.99 | 279 | 834 | 7,830 | 8.1 K to 7.8 K (-3.44 %) |
Aug 08 2011 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | Chief Financial Off ... | Payment of Exercise | F | 1.98 | 279 | 552 | 8,109 | 8.4 K to 8.1 K (-3.33 %) |
Aug 08 2011 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | Chief Financial Off ... | Payment of Exercise | F | 1.77 | 279 | 494 | 8,388 | 8.7 K to 8.4 K (-3.22 %) |
Jul 12 2011 | OXBT | TENAX THERAPEUTICS ... | Kiral Richard M | Director | Option Exercise | A | 1.93 | 1,334 | 2,575 | 1,334 | |
Jul 12 2011 | OXBT | TENAX THERAPEUTICS ... | Kiral Richard M | Director | Option Exercise | A | 2.05 | 1,334 | 2,735 | 1,334 | |
Jul 12 2011 | OXBT | TENAX THERAPEUTICS ... | Kiral Richard M | Director | Option Exercise | A | 1.92 | 1,334 | 2,561 | 1,334 | |
Jul 12 2011 | OXBT | TENAX THERAPEUTICS ... | Kiral Richard M | Director | Option Exercise | A | 2.15 | 1,334 | 2,868 | 1,334 | |
Jul 12 2011 | OXBT | TENAX THERAPEUTICS ... | Kiral Richard M | Director | Option Exercise | A | 2.11 | 1,334 | 2,815 | 1,334 | |
Jul 12 2011 | OXBT | TENAX THERAPEUTICS ... | Kiral Richard M | Director | Option Exercise | A | 2.53 | 1,334 | 3,375 | 1,334 | |
Jul 12 2011 | OXBT | TENAX THERAPEUTICS ... | Kiral Richard M | Director | Option Exercise | A | 3.04 | 1,334 | 4,055 | 1,334 | |
Jul 12 2011 | OXBT | TENAX THERAPEUTICS ... | Kiral Richard M | Director | Option Exercise | A | 2.74 | 1,334 | 3,655 | 1,334 | |
Jul 12 2011 | OXBT | TENAX THERAPEUTICS ... | Kiral Richard M | Director | Option Exercise | A | 2.89 | 1,334 | 3,855 | 1,334 | |
Jul 12 2011 | OXBT | TENAX THERAPEUTICS ... | Kiral Richard M | Director | Option Exercise | A | 2.97 | 1,334 | 3,962 | 1,334 | |
Jul 12 2011 | OXBT | TENAX THERAPEUTICS ... | Kiral Richard M | Director | Option Exercise | A | 5.00 | 1,334 | 6,670 | 1,334 | |
Jul 12 2011 | OXBT | TENAX THERAPEUTICS ... | Kiral Richard M | Director | Grant | A | 3.10 | 6,951 | 21,548 | 6,951 | 0 to 7 K |
Jun 01 2011 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | CHIEF FINANCIAL OFF ... | Option Exercise | A | 1.84 | 667 | 1,227 | 667 | |
Jun 01 2011 | OXBT | TENAX THERAPEUTICS ... | Jebsen Michael B | CHIEF FINANCIAL OFF ... | Option Exercise | A | 1.93 | 667 | 1,287 | 667 |